PGNY NASDAQ
Credit Risk of going bust: lower than 79% of companies Debt: 1.2% of company value Bonds: none of note held by US funds details ▾
If the stock fell to about $0.04 (down 99.9%), Progyny, Inc. would be worth roughly what it owes.
Total debt $27.0M against a stock market value of $2.16B.
Distance to default 9.41 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $13.5M (short-term plus half of long-term), stock volatility 53.3%; Altman Z'' 6.60. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
New York City, NY 10018
US
Progyny, Inc. functions as a benefits management corporation, dedicated to providing specialized solutions for fertility and broader family-building initiatives to employers throughout the United States. Its core fertility offering is characterized by a distinctive benefits plan architecture, paired with personalized, white-glove member support services and access to a meticulously chosen network of top-tier fertility specialists. Additionally, the company presents Progyny Rx, an all-encompassing pharmacy benefits solution that ensures its members can readily acquire the essential medications for their treatments. Moreover, Progyny facilitates employer-sponsored reimbursement programs to support surrogacy and adoption journeys. The company, which was established in 2008 and has its main offices in New York City, previously operated as Auxogyn, Inc. before adopting the Progyny, Inc. moniker in 2015.
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Cummings Melissa B | F-InKind | 1,559 | $27.39 | 2026-10-14 |
| Cummings Melissa B | S-Sale | 1,879 | $28.00 | 2026-10-14 |
| Swartz Allison | S-Sale | 3,903 | $26.10 | 2026-09-23 |
| Clapp Geoffrey | F-InKind | 819 | $27.38 | 2026-09-17 |
| GORDON KEVIN K | S-Sale | 11,500 | $27.12 | 2026-09-10 |